Raffaele Pezzani

6.5k total citations · 1 hit paper
87 papers, 3.1k citations indexed

About

Raffaele Pezzani is a scholar working on Molecular Biology, Plant Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Raffaele Pezzani has authored 87 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 20 papers in Plant Science and 19 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Raffaele Pezzani's work include Adrenal and Paraganglionic Tumors (16 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Phytochemicals and Antioxidant Activities (10 papers). Raffaele Pezzani is often cited by papers focused on Adrenal and Paraganglionic Tumors (16 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Phytochemicals and Antioxidant Activities (10 papers). Raffaele Pezzani collaborates with scholars based in Italy, Iran and Chile. Raffaele Pezzani's co-authors include Javad Sharifi‐Rad, Bahare Salehi, Mehdi Sharifi‐Rad, Natália Martins, Patrick Valère Tsouh Fokou, Paolo Zucca, Marcello Iriti, Sara Vitalini, Miquel Martorell and Marco Redaelli and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Raffaele Pezzani

84 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Therapeutic Potential of Naringenin: A Review of Clinical Trials

2019 598 citations Bahare Salehi, Patrick Valère Tsouh Fokou et al. profile →

Peers

Countries citing papers authored by Raffaele Pezzani

Since Specialization

Citations

This map shows the geographic impact of Raffaele Pezzani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Pezzani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Pezzani more than expected).

Fields of papers citing papers by Raffaele Pezzani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Pezzani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Pezzani. The network helps show where Raffaele Pezzani may publish in the future.

Co-authorship network of co-authors of Raffaele Pezzani

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Pezzani. A scholar is included among the top collaborators of Raffaele Pezzani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Pezzani. Raffaele Pezzani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rosa canina and Cancer: Which Evidence? 2024 ·Journal of Herbal Medicine ·(unknown), Rajesh Kumar, Seetha Harilal, (unknown), (unknown), Patrick Valère Tsouh Fokou, Raffaele Pezzani	1
2	COVID 19: Prevention and treatment through the Indian perspective 2024 ·Cytokine ·Harish Chandra, (unknown), Rajendra Prasad, (unknown), Nitin Bhardwaj, Kartikey Kumar Gupta, (unknown), Manisha Nigam, Raffaele Pezzani, (unknown), Henrique Douglas Melo Coutinho, Abhay Prakash Mishra	1
3	A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma 2024 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown), Raffaele Pezzani, Babak Sokouti	10
4	A systematic investigation and network interaction analysis on preventive treatments against HepG2 cancer cells from a genomic-level perspective 2023 ·Biochemical Engineering Journal ·(unknown), Solmaz Asnaashari, Raffaele Pezzani, Babak Sokouti	1
5	Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy 2023 ·Cell Communication and Signaling ·Javad Sharifi‐Rad, Véronique Seidel, (unknown), (unknown), Antonio García‐Ríos, Valeska Ormazábal, Felipe Zúñiga, (unknown), Raffaele Pezzani, Alibek Ydyrys, (unknown), Miquel Martorell, Daniela Călina, William C. Cho	53
6	Natural essential oils as a new therapeutic tool in colorectal cancer 2022 ·Cancer Cell International ·Stefanıa Garzoli, Pedro Alarcón, Gulnaz Seitimova, (unknown), Miquel Martorell, Farukh Sharopov, Patrick Valère Tsouh Fokou, (unknown), Lauve Rachel Tchokouaha Yamthé, Francisco Les, Guillermo Cásedas, Víctor López, Marcello Iriti, Javad Sharifi‐Rad, Eda Sönmez Gürer, Daniela Călina, Raffaele Pezzani, Sara Vitalini	25
7	Plant Natural Compounds in the Treatment of Adrenocortical Tumors 2021 ·International Journal of Endocrinology ·Jacopo Manso, Javad Sharifi‐Rad, Wissam Zam, Patrick Valère Tsouh Fokou, Miquel Martorell, Raffaele Pezzani	5
8	Cocoa and cocoa bean shells role in human health: An updated review 2021 ·Journal of Food Composition and Analysis ·(unknown), Maria Atanassova, Tugba Boyunegmez Tumer, Gianluca Caruso, Gizem Antika, Somesh Sharma, Javad Sharifi‐Rad, Raffaele Pezzani	41
9	Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Cancer Growth 2020 ·Molecular Cancer Therapeutics ·Francesca Trotta, Paola Avena, Adele Chimento, Vittoria Rago, Arianna De Luca, (unknown), (unknown), Rocco Malivindi, Francesco Fallo, Raffaele Pezzani, Catia Pilon, Francesco M. Lasorsa, Simona N. Barile, Luigi Palmieri, Antônio Marcondes Lerário, Vincenzo Pezzi, Ivan Casaburi, Rosa Sirianni	16
10	Nootkatone Inhibits Acute and Chronic Inflammatory Responses in Mice 2020 ·Molecules ·Lindaiane Bezerra Rodrigues, (unknown), (unknown), (unknown), Maria Rayane Correia de Oliveira, Anita Oliveira Brito Pereira Bezerra Martins, Jaime Ribeiro‐Filho, Henrique Douglas Melo Coutinho, Fabíolla Rocha Santos Passos, Lucindo José Quintans‐Júnior, Irwin Rose Alencar de Menezes, Raffaele Pezzani, Sara Vitalini	39
11	Plant natural products with anti-thyroid cancer activity 2020 ·Fitoterapia ·Javad Sharifi‐Rad, Sadegh Rajabi, Miquel Martorell, María Dolores López, (unknown), Susi Barollo, Decio Armanini, Patrick Valère Tsouh Fokou, Giuseppe Zagotto, Giovanni Ribaudo, Raffaele Pezzani	22
12	Erythrina suberosa: Ethnopharmacology, Phytochemistry and Biological Activities 2019 ·SHILAP Revista de lepidopterología ·(unknown), Yasaman Taheri, Javad Sharifi‐Rad, Miquel Martorell, William C. Cho, Raffaele Pezzani	7
13	Circulating miRNA Expression Profiling in Primary Aldosteronism 2019 ·Frontiers in Endocrinology ·Ábel Decmann, Gábor Nyírő, (unknown), (unknown), Irina Bancos, Ravinder Jeet Kaur, Raffaele Pezzani, Maurizio Iacobone, Ivana Kraljević, Darko Kaštelan, Mirko Parasiliti‐Caprino, Mauro Maccario, (unknown), Daniel Heinrich, Martín Reincke, Attila Patócs, Péter Igaz	24
14	Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors 2018 ·Endocrine ·Pál Perge, Ábel Decmann, Raffaele Pezzani, Irina Bancos, Ambrogio Fassina, Michaela Luconi, Letizia Canu, Miklós Tóth, Marco Boscaro, Attila Patócs, Péter Igaz	23
15	Programmed Cell Death, from a Cancer Perspective: An Overview 2018 ·Molecular Diagnosis & Therapy ·Abhay Prakash Mishra, Bahare Salehi, Mehdi Sharifi‐Rad, Raffaele Pezzani, Farzad Kobarfard, Javad Sharifi‐Rad, Manisha Nigam	135
16	Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors 2017 ·Scientific Reports ·Pál Perge, Henriett Butz, Raffaele Pezzani, Irina Bancos, Zsolt Nagy, Krisztina Pálóczi, Gábor Nyírő, Ábel Decmann, Erna Pap, Michaela Luconi, Massimo Mannelli, Edit I. Buzás, Miklós Tóth, Marco Boscaro, Attila Patócs, Péter Igaz	51
17	Adrenocortical Carcinoma: in the Search for a Pre-Operative Biomarker 2017 ·Acta Endocrinologica (Bucharest) ·Raffaele Pezzani	1
18	The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 2016 ·Investigational New Drugs ·Raffaele Pezzani, Beatrice Rubin, Loris Bertazza, Marco Redaelli, Susi Barollo, (unknown), Enke Baldini, Caterina Mian, Carla Mucignat‐Caretta, Carla Scaroni, Franco Mantero, Salvatore Ulisse, Maurizio Iacobone, Marco Boscaro	14
19	Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors 2015 ·Cancer Investigation ·Beatrice Rubin, (unknown), Marco Redaelli, Carla Mucignat‐Caretta, Susi Barollo, Loris Bertazza, Caterina Mian, Corrado Betterle, Maurizio Iacobone, Ambrogio Fassina, Marco Boscaro, Raffaele Pezzani, Franco Mantero	4
20	Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations 2013 ·Thyroid ·Susi Barollo, Raffaele Pezzani, (unknown), Marco Redaelli, Laura Zambonin, Beatrice Rubin, Loris Bertazza, (unknown), Carla Mucignat‐Caretta, Alessandro Bulfone, Gianmaria Pennelli, Eric Casal Ide, Maria Rosa Pelizzo, Franco Mantero, Stefano Moro, Caterina Mian	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact